Ultragenyx Pharmaceutical Inc. buy Truist Financial Co.
Start price
05.11.25
/
50%
€27.80
Target price
05.11.26
€78.31
Performance (%)
-31.60%
Price
09:32
?
Summary
This prediction is currently active. Massive losses of -31.60% have been the result for the BUY prediction by Truist_Financial_Co_. This prediction currently runs until 05.11.26. The prediction end date can be changed by Truist_Financial_Co_ at any time. Truist_Financial_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Ultragenyx Pharmaceutical Inc. | -7.371% | -7.371% |
| iShares Core DAX® | -1.862% | -1.624% |
| iShares Nasdaq 100 | -3.322% | 3.321% |
| iShares Nikkei 225® | -2.299% | 3.437% |
| iShares S&P 500 | -1.313% | 2.435% |
Comments by Truist_Financial_Co_ for this prediction
In the thread Ultragenyx Pharmaceutical Inc. diskutieren
Ultragenyx Pharmaceutical (NASDAQ:RARE) had its price target lowered by analysts at Truist Financial Corporation from $100.00 to $90.00. They now have a "buy" rating on the stock.
Ratings data for RARE provided by MarketBeat